{"title":"解决印度 GRAND 研究方案中的偏差来源。","authors":"Narsingh Verma MBBS, MD, Noriko Matsushita MPH, Ebtehal Salman PhD, Takayoshi Ohkubo MD, PhD, Yutaka Imai MD, PhD","doi":"10.1111/jch.14901","DOIUrl":null,"url":null,"abstract":"<p>One additional note to mention is that the sample size of our study population is not considered large compared to India's population, and there were indeed limitations in our study, however, clinical studies using home BP monitoring (HBPM) in India are limited. Our GRAND Study is the first step toward understanding the “real” BP control status using both clinic BP and home BP and the current hypertension situation in India. We believe that the GRAND Study will contribute to understanding hypertension management based on HBPM, and we anticipate that future national studies in India will also incorporate HBPM.</p><p>We appreciate the constructive feedback on our protocol. We believe the mentioned insights align well with our goal of providing a comprehensive and accurate assessment of hypertension prevalence and BP control in India. We are committed to incorporating these insights in analyzing the results of the study and in future publications to ensure proper interpretations of the study findings and implications.</p><p>Noriko Matsushita and Ebtehal Salman is an employee of Omron Healthcare Co., Ltd. Takayoshi Ohkubo and Yutaka Imai has received grants from Omron Healthcare Co., Ltd.</p><p>This study was supported and research funded by Omron Healthcare Co., Ltd.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":"26 12","pages":"1531-1532"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.14901","citationCount":"0","resultStr":"{\"title\":\"Addressing sources of bias in the GRAND study protocol in India\",\"authors\":\"Narsingh Verma MBBS, MD, Noriko Matsushita MPH, Ebtehal Salman PhD, Takayoshi Ohkubo MD, PhD, Yutaka Imai MD, PhD\",\"doi\":\"10.1111/jch.14901\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>One additional note to mention is that the sample size of our study population is not considered large compared to India's population, and there were indeed limitations in our study, however, clinical studies using home BP monitoring (HBPM) in India are limited. Our GRAND Study is the first step toward understanding the “real” BP control status using both clinic BP and home BP and the current hypertension situation in India. We believe that the GRAND Study will contribute to understanding hypertension management based on HBPM, and we anticipate that future national studies in India will also incorporate HBPM.</p><p>We appreciate the constructive feedback on our protocol. We believe the mentioned insights align well with our goal of providing a comprehensive and accurate assessment of hypertension prevalence and BP control in India. We are committed to incorporating these insights in analyzing the results of the study and in future publications to ensure proper interpretations of the study findings and implications.</p><p>Noriko Matsushita and Ebtehal Salman is an employee of Omron Healthcare Co., Ltd. Takayoshi Ohkubo and Yutaka Imai has received grants from Omron Healthcare Co., Ltd.</p><p>This study was supported and research funded by Omron Healthcare Co., Ltd.</p>\",\"PeriodicalId\":50237,\"journal\":{\"name\":\"Journal of Clinical Hypertension\",\"volume\":\"26 12\",\"pages\":\"1531-1532\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.14901\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jch.14901\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.14901","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Addressing sources of bias in the GRAND study protocol in India
One additional note to mention is that the sample size of our study population is not considered large compared to India's population, and there were indeed limitations in our study, however, clinical studies using home BP monitoring (HBPM) in India are limited. Our GRAND Study is the first step toward understanding the “real” BP control status using both clinic BP and home BP and the current hypertension situation in India. We believe that the GRAND Study will contribute to understanding hypertension management based on HBPM, and we anticipate that future national studies in India will also incorporate HBPM.
We appreciate the constructive feedback on our protocol. We believe the mentioned insights align well with our goal of providing a comprehensive and accurate assessment of hypertension prevalence and BP control in India. We are committed to incorporating these insights in analyzing the results of the study and in future publications to ensure proper interpretations of the study findings and implications.
Noriko Matsushita and Ebtehal Salman is an employee of Omron Healthcare Co., Ltd. Takayoshi Ohkubo and Yutaka Imai has received grants from Omron Healthcare Co., Ltd.
This study was supported and research funded by Omron Healthcare Co., Ltd.
期刊介绍：
The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
